Canada Life’s Ares Capital ARCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$26.1M Buy
1,445,280
+81,611
+6% +$1.58M 0.05% 312
2025
Q4
$27.7M Buy
1,363,669
+484,867
+55% +$9.78M 0.05% 304
2025
Q3
$19.1M Buy
878,802
+420,728
+92% +$9.35M 0.03% 442
2025
Q2
$10.1M Buy
458,074
+16,081
+4% +$342K 0.02% 544
2025
Q1
$9.82M Buy
441,993
+76,574
+21% +$1.74M 0.02% 562
2024
Q4
$7.99M Sell
365,419
-24,571
-6% -$530K 0.01% 636
2024
Q3
$8.18M Buy
389,990
+2,383
+0.6% +$49.5K 0.01% 638
2024
Q2
$8.08M Buy
387,607
+11,528
+3% +$241K 0.02% 621
2024
Q1
$7.84M Buy
376,079
+56,514
+18% +$1.14M 0.02% 632
2023
Q4
$6.36M Sell
319,565
-32,250
-9% -$629K 0.01% 670
2023
Q3
$6.85M Sell
351,815
-154,060
-30% -$2.99M 0.02% 614
2023
Q2
$9.56M Buy
505,875
+29,130
+6% +$538K 0.02% 529
2023
Q1
$8.73M Buy
476,745
+185,297
+64% +$3.5M 0.02% 565
2022
Q4
$5.42M Buy
291,448
+5,438
+2% +$102K 0.01% 699
2022
Q3
$4.82M Sell
286,010
-9,982
-3% -$193K 0.01% 699
2022
Q2
$5.32M Buy
295,992
+202,136
+215% +$3.98M 0.01% 681
2022
Q1
$2.09M Sell
93,856
-15,576
-14% -$332K ﹤0.01% 1177
2021
Q4
$2.31M Sell
109,432
-3,350
-3% -$69.6K ﹤0.01% 1120
2021
Q3
$2.31M Buy
112,782
+15,812
+16% +$317K 0.01% 1091
2021
Q2
$1.9M Buy
96,970
+6,025
+7% +$117K ﹤0.01% 1186
2021
Q1
$1.69M Sell
90,945
-15,113
-14% -$272K ﹤0.01% 1247
2020
Q4
$1.79M Buy
106,058
+5,974
+6% +$92.6K ﹤0.01% 1212
2020
Q3
$1.4M Buy
100,084
+24,713
+33% +$352K ﹤0.01% 1241
2020
Q2
$1.08M Buy
75,371
+8,739
+13% +$118K ﹤0.01% 1405
2020
Q1
$725K Sell
66,632
-22,403
-25% -$378K ﹤0.01% 1452
2019
Q4
$1.65M Buy
+89,035
New +$1.65M ﹤0.01% 1247
2019
Q3
Sell
-85,224
Closed -$1.53M 1185
2019
Q2
$1.53M Sell
85,224
-451
-0.5% -$7.98K ﹤0.01% 1332
2019
Q1
$1.46M Buy
85,675
+23,000
+37% +$385K ﹤0.01% 1229
2018
Q4
$943K Buy
62,675
+5,921
+10% +$98K ﹤0.01% 1419
2018
Q3
$977K Sell
56,754
-1,900
-3% -$32.6K ﹤0.01% 1533
2018
Q2
$965K Buy
58,654
+2,299
+4% +$37.8K ﹤0.01% 1541
2018
Q1
$896K Buy
+56,355
New +$893K ﹤0.01% 1549
2015
Q3
Sell
-167
Closed -$3K 2446
2015
Q2
$3K Buy
+167
New +$2.79K ﹤0.01% 2597
2014
Q2
Sell
-14,901
Closed -$261K 2421
2014
Q1
$261K Hold
14,901
﹤0.01% 1013
2013
Q4
$266K Hold
14,901
﹤0.01% 985
2013
Q3
$257K Buy
+14,901
New +$261K ﹤0.01% 890

Other funds holding ARCC

Canada Life's ARCC Position: Q1 2026 in Review

Canada Life increased its Ares Capital (ARCC) stake by 6% in Q1 2026, buying an estimated $1.58M and bringing the position to 1,445,280 shares worth $26.1M. The position accounts for 0.05% of the portfolio, ranked #312.

Canada Life first reported a position in ARCC in Q3 2013 and has held it in 36 quarters since. The position peaked at $27.7M in Q4 2025. 807 funds tracked by Wall St. Rank hold ARCC as of Q1 2026.

  • Canada Life held 1,445,280 shares of Ares Capital worth $26.1M as of Q1 2026.
  • Canada Life bought 81,611 Ares Capital shares in Q1 2026, an estimated $1.58M.
  • Ares Capital made up 0.05% of Canada Life's portfolio in Q1 2026, its #312 holding.
  • Canada Life first reported a position in Ares Capital in Q3 2013 and has held it in 36 quarters since.
  • Canada Life's Ares Capital position peaked at $27.7M in Q4 2025.
  • 807 funds tracked by Wall St. Rank held Ares Capital as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.